Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03156946
Other study ID # 69HCL17_0033
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 5, 2018
Est. completion date December 22, 2022

Study information

Verified date January 2024
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Breastfeeding has a fundamental impact on the short-, medium- and long-term health of children and has an important impact on women's health. Breastfeeding protects against gastrointestinal and respiratory illnesses and is associated with better cognitive development in childhood, particularly in preterm infants. Despite these potential benefits, preterm infants experience lower rates of breastfeeding initiation and continuation compared to term infants. The use of breastfeeding peer support initiatives, in which advice is given by experienced and trained peer counselors, is an effective way to promote and support breastfeeding, regardless of a woman's socioeconomic status. Several small studies have shown that breastfeeding peer support initiatives were effective for preterm infants and that this efficacy was increased by the co-intervention of lactation consultants. The purpose of this study is to develop and to evaluate the effectiveness of a breastfeeding support program among mother-preterm infant dyads in Europe, by evaluating the impact of the intervention on 1) breastfeeding rates, 2) morbidity and mortality during the hospitalization, 3) children's cognitive development and behavior 4) mothers' mental health, 4) costs benefits. The breastfeeding support program will include peer counselors under the supervision of lactation consultants. Breastfeeding counselors will be voluntary mothers who have had a positive breastfeeding experience with at least one preterm infant. After a training course, they will meet the future or new mothers by face-to-face and share their experiences at least once a week during hospitalization and provide phone support up to 1 month after discharge from hospital. The study design will be a stepped wedge cluster trial conducted in 8 NICU in Europe (France, Switzerland and Belgium). Infants and mothers will be followed up from the time of hospitalization in the maternity and NICU up to 6 months after the discharge. The cost analysis will be performed in a subgroup of mother-preterm infant dyads that will be followed up at 24-months after their discharge


Recruitment information / eligibility

Status Completed
Enrollment 1774
Est. completion date December 22, 2022
Est. primary completion date December 22, 2022
Accepts healthy volunteers No
Gender All
Age group N/A to 35 Weeks
Eligibility Inclusion Criteria: - any infant born <35 weeks' gestation, - hospitalised in NICU before 24 hours old - and younger than 168 hours (7 days) old. Exclusion Criteria: - infant with foetal malformation that is life-threatening - infant with medical contraindication for breastfeeding - parent(s)' non-consent to be involved in the study - mother with prolonged medical contraindication for breastfeeding - mother with psychiatric disorders making breastfeeding support impossible - if no communication is possible with the mother - if the level of communication with the mother does not allow breastfeeding support, with or without a third party

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
breastfeeding mother-to-mother support
The mother-infant dyads in the intervention arm will receive breastfeeding mother-to-mother support from the hospitalization in the maternity and NICU up to 1 month after discharge. The intervention will be in addition to the usual or routine care. Breastfeeding counselors will be voluntary mothers who breastfed their own preterm infant (aged between 6 months and 5 years at the time of the study) for a minimum of 2 months, and who have had a positive personal breastfeeding experience, and who have undertaken a training course.
Control
The mother-infant dyads in the control arm will continue to receive the usual/routine care provided by participating centers during the hospitalization and Mother and Infant Protection service after discharge.

Locations

Country Name City State
Belgium CHC Clinique St-Vincent Rocourt
France Hôpital Femme Mère Enfant Bron
France Hôpital Nord Ouest - Villefranche Gleizé
France CHU de Grenoble Grenoble
France CH Lyon Sud Pierre-Bénite
France CHU site Félix Guyon Saint-Denis Réunion
France Hôpital des Enfants Toulouse
Switzerland CHU vaudois Lausanne

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Countries where clinical trial is conducted

Belgium,  France,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Breastfeeding continuation rates Breastfeeding will be defined as the consumption of any mother's own milk. It will be classed as exclusive when all of the fed milk is the mother's own milk, or mixed when it will be completed by other milk and/or food. at corrected postnatal age of 2 months
Secondary Rate of breastfeeding initiated at 2 months of corrected age
Secondary Breastfeeding rate at 2 months of corrected age
Secondary Breastfeeding rate at the end of NICU stay
Secondary Breastfeeding rate at 6 months of corrected age
Secondary Breastfeeding duration at 6 months of corrected age
Secondary Neonatal severe complications Morbidity outcomes will include intraventricular haemorrhage grade=3, periventricular leucomalacia, sepsis (proven or clinical), persistent ductus arteriosus requiring treatment, necrotising enterocolitis grade=2, and bronchopulmonary dysplasia (need of oxygen and/or ventilation support at 36 weeks of corrected age), retinopathy of prematurity grade>2. at 36 weeks of corrected age
Secondary Death rates Morbidity outcomes will include intraventricular haemorrhage grade=3, periventricular leucomalacia, sepsis (proven or clinical), persistent ductus arteriosus requiring treatment, necrotising enterocolitis grade=2, and bronchopulmonary dysplasia (need of oxygen and/or ventilation support at 36 weeks of corrected age), retinopathy of prematurity grade>2. at 36 weeks of corrected age
Secondary Infant behaviours Behavior will be assessed by the validated Infant Behavior questionnaire completed by mothers. at corrected postnatal age of 6 months
Secondary Mother-Infant bonding Disabilities will include cerebral palsy, mental retardation assessed by the developmental quotient less than 85 on the Brunet- Lézine scale, and visual and hearing deficits. -Infant bonding assessed by the Mother-Infant Bonding Scale (MIBS) at corrected postnatal age of 6 months
Secondary Disability rate Disabilities will include cerebral palsy, mental retardation assessed by the developmental quotient less than 85 on the Brunet- Lézine scale, and visual and hearing deficits. at corrected postnatal age of 24 months
Secondary Neurodevelopment rate by Brunet Lézine scale at corrected postnatal age of 24 months
Secondary Anxiety by the Hospital Anxiety and Depression Scale (HADS) at corrected postnatal age of 6 months
Secondary Depression by the Edinburgh Postnatal Depression Scale. at corrected postnatal age of 6 months
Secondary Posttraumatic stress by the Post-traumatic stress disorder Checklist version DSM-5 (PCL-5) at corrected postnatal age of 6 months
Secondary Parents stress by the Parenting Stress Index Fourth Edition Short Form (PSI-4 SF at corrected postnatal age of 6 months
Secondary Costs effectiveness of breastfeeding Costs will include initial hospitalization, hospital readmissions, outpatient visits and tests. up to first two years of life
Secondary cost consequence of breastfeeding Costs will include hospitalization rate and mortality between the two strategies. up to first two years of life
Secondary Feasibility of the breastfeeding support program To assess the feasibility of the intervention, we will depict : - the socio-demographic characteristics of breastfeeding counselors - and the number of contacts between mothers and breastfeeding counselors (frequency and duration) and the information 24 months
Secondary Acceptability of the breastfeeding support program To assess the acceptability of the breastfeeding support program, we will collect :
the perception of breastfeeding support by mothers and their spouses, by staff members (lactation consultant, nurses) in each participating centers and by breastfeeding counselors.
the number of mothers who refuse to be managed by a breastfeeding counselors and their reasons,
the duration of each breastfeeding counselor intervention and the number of mothers who will stop the intervention before 1 month after the hospital discharge.
24 months
See also
  Status Clinical Trial Phase
Completed NCT04624347 - NEOVIDEO : Impact of Monitoring Motor Activity by Video Analysis on the Sleep of Very Preterm Infants N/A
Completed NCT02377050 - Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates N/A